The Survival Benefit of Postoperative Bacterial Infections in Patients With Glioblastoma Multiforme: Myth or Reality?

Glioblastoma multiforme (GBM), the most common malignant brain tumor, universally carries a poor prognosis. Despite aggressive multimodality treatment, the median survival is ~18–20 months, depending on molecular subgroups. A long history of observations suggests antitumor effects of bacterial infec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazim, Syed Faraz, Martinez, Erick, Hough, Tyler J., Spangler, Benjamin Q., Bowers, Christian A., Chohan, Muhammad Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894197/
https://www.ncbi.nlm.nih.gov/pubmed/33613432
http://dx.doi.org/10.3389/fneur.2021.615593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894197/
https://www.ncbi.nlm.nih.gov/pubmed/33613432
http://dx.doi.org/10.3389/fneur.2021.615593

Ejemplares similares